These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 786888)

  • 1. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Infect Immun; 1976 Sep; 14(3):597-602. PubMed ID: 786888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on bacteriophages of Clostridium botulinum type C isolates from different sources and the role of certain phages in toxigenicity.
    Hariharan H; Mitchell WR
    Appl Environ Microbiol; 1976 Jul; 32(1):145-58. PubMed ID: 61735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K; Iida H
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
    Zhou Y; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage-conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M
    Jpn J Med Sci Biol; 1977 Feb; 30(1):40-3. PubMed ID: 406437
    [No Abstract]   [Full Text] [Related]  

  • 7. The stability of toxigenicity in Clostridium botulinum types C and D.
    Oguma K
    J Gen Microbiol; 1976 Jan; 92(1):67-75. PubMed ID: 1107486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on nonconverting phage, c-n71, obtained from a nontoxigenic strain of Clostridium botulinum type C.
    Oguma K; Iida H; Inoue K
    Jpn J Microbiol; 1975 Jun; 19(3):167-72. PubMed ID: 1100888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D.
    Fujii N; Oguma K; Yokosawa N; Kimura K; Tsuzuki K
    Appl Environ Microbiol; 1988 Jan; 54(1):69-73. PubMed ID: 3278690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics of Clostridium botulinum group III strains.
    Sakaguchi Y; Suzuki T; Yamamoto Y; Nishikawa A; Oguma K
    Res Microbiol; 2015 May; 166(4):318-25. PubMed ID: 25111022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.
    Eklund MW; Poysky FT; Meyers JA; Pelroy GA
    Science; 1974 Nov; 186(4162):456-8. PubMed ID: 4606682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
    Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin.
    Ciccarelli AS; Whaley DN; McCroskey LM; Gimenez DF; Dowell VR; Hatheway CL
    Appl Environ Microbiol; 1977 Dec; 34(6):843-8. PubMed ID: 74236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive inhibition between different Clostridium botulinum types and strains.
    Eklund MW; Poysky FT; Peterson ME; Paranjpye RN; Pelroy GA
    J Food Prot; 2004 Dec; 67(12):2682-7. PubMed ID: 15633672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxin production and phage in Clostridium botulinum].
    Iida H
    Nihon Saikingaku Zasshi; 1985 Sep; 40(5):827-34. PubMed ID: 3908743
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinction between Clostridium botulinum type A strains associated with food-borne botulism and those with infant botulism in Japan in intraintestinal toxin production in infant mice and some other properties.
    Tabita K; Sakaguchi S; Kozaki S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):251-6. PubMed ID: 1905658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adsorption of Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K; Iida H; Sugiyama H
    Jpn J Med Sci Biol; 1979 Apr; 32(2):125-6. PubMed ID: 396393
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
    Kouguchi H; Watanabe T; Sagane Y; Ohyama T
    Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.
    Eklund MW; Poysky FT; Peterson ME; Meyers JA
    Infect Immun; 1976 Sep; 14(3):793-803. PubMed ID: 965096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorption to Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K; Sugiyama H
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):61-4. PubMed ID: 362423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.